1
|
Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure.
|
J Clin Invest
|
1995
|
2.05
|
2
|
Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.
|
J Clin Invest
|
1983
|
2.05
|
3
|
Inflammatory mediators in late antigen-induced rhinitis.
|
N Engl J Med
|
1985
|
1.84
|
4
|
Detection of tissue kallikrein in the bronchoalveolar lavage fluid of asthmatic subjects.
|
J Clin Invest
|
1987
|
1.80
|
5
|
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population.
|
JAMA
|
2000
|
1.62
|
6
|
Antigen-specific IgE and IgA antibodies in bronchoalveolar lavage fluid are associated with stronger antigen-induced late phase reactions.
|
Clin Exp Allergy
|
2001
|
1.46
|
7
|
Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement.
|
J Clin Invest
|
1985
|
1.45
|
8
|
Kinins are generated during experimental rhinovirus colds.
|
J Infect Dis
|
1988
|
1.44
|
9
|
Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells.
|
Am Rev Respir Dis
|
1989
|
1.41
|
10
|
Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma.
|
Am Rev Respir Dis
|
1990
|
1.40
|
11
|
Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.
|
Am Rev Respir Dis
|
1991
|
1.38
|
12
|
Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.
|
J Allergy Clin Immunol
|
1991
|
1.37
|
13
|
Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids.
|
J Immunol
|
1995
|
1.33
|
14
|
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE.
|
J Immunol
|
1987
|
1.32
|
15
|
Identification of a chymotrypsin-like proteinase in human mast cells.
|
J Immunol
|
1986
|
1.29
|
16
|
Upper respiratory tract environmental tobacco smoke sensitivity.
|
Am Rev Respir Dis
|
1991
|
1.27
|
17
|
Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line.
|
J Virol
|
1998
|
1.26
|
18
|
Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge.
|
Am Rev Respir Dis
|
1992
|
1.21
|
19
|
Characterization of vagal afferent subtypes stimulated by bradykinin in guinea pig trachea.
|
J Pharmacol Exp Ther
|
1999
|
1.20
|
20
|
Bradykinin antagonists.
|
Annu Rev Pharmacol Toxicol
|
1991
|
1.19
|
21
|
Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells.
|
Immunology
|
1992
|
1.14
|
22
|
Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.
|
J Immunol
|
1999
|
1.14
|
23
|
Epithelia cells as regulators of airway inflammation.
|
J Allergy Clin Immunol
|
1998
|
1.12
|
24
|
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
|
J Clin Invest
|
1985
|
1.11
|
25
|
In vivo release of inflammatory mediators by hyperosmolar solutions.
|
Am Rev Respir Dis
|
1988
|
1.08
|
26
|
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
|
J Immunol
|
1986
|
1.05
|
27
|
Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation.
|
J Clin Invest
|
1995
|
1.04
|
28
|
Cigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine production.
|
Eur Respir J
|
2009
|
1.02
|
29
|
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects.
|
J Allergy Clin Immunol
|
2001
|
1.00
|
30
|
Human lung macrophages induce histamine release from basophils and mast cells.
|
Am Rev Respir Dis
|
1985
|
1.00
|
31
|
Characterization and localization of human renal kininogen.
|
J Biol Chem
|
1981
|
1.00
|
32
|
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals.
|
J Clin Invest
|
1985
|
0.99
|
33
|
Detection and partial characterization of a human mast cell carboxypeptidase.
|
J Immunol
|
1987
|
0.99
|
34
|
Effect of intranasal capsaicin on symptoms and mediator release.
|
J Pharmacol Exp Ther
|
1991
|
0.98
|
35
|
Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids.
|
N Engl J Med
|
1987
|
0.98
|
36
|
Human lung macrophages enhance and inhibit lymphocyte proliferation.
|
J Immunol
|
1984
|
0.98
|
37
|
Stable expression of the human kinin B1 receptor in Chinese hamster ovary cells. Characterization of ligand binding and effector pathways.
|
J Biol Chem
|
1997
|
0.97
|
38
|
A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection.
|
J Infect Dis
|
1990
|
0.97
|
39
|
Basophil histamine release induced by a substance from stimulated human platelets.
|
J Immunol
|
1986
|
0.97
|
40
|
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
|
Am Rev Respir Dis
|
1990
|
0.96
|
41
|
Role of NF-kappa B in cytokine production induced from human airway epithelial cells by rhinovirus infection.
|
J Immunol
|
2000
|
0.96
|
42
|
Studies on the allergic and nonallergic nasal inflammation.
|
J Allergy Clin Immunol
|
1988
|
0.95
|
43
|
Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge.
|
J Clin Invest
|
1987
|
0.95
|
44
|
Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells.
|
Int Immunopharmacol
|
2001
|
0.95
|
45
|
Oral prednisone therapy in experimental rhinovirus infections.
|
J Allergy Clin Immunol
|
1996
|
0.95
|
46
|
A human lung mast cell chymotrypsin-like enzyme. Identification and partial characterization.
|
J Clin Invest
|
1986
|
0.94
|
47
|
Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1.
|
J Pharmacol Exp Ther
|
1992
|
0.94
|
48
|
Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells.
|
J Virol
|
1998
|
0.94
|
49
|
Dose-dependent effects of capsaicin nasal challenge: in vivo evidence of human airway neurogenic inflammation.
|
J Allergy Clin Immunol
|
1997
|
0.94
|
50
|
Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells.
|
Am Rev Respir Dis
|
1985
|
0.93
|
51
|
Nerve growth factor expression and release in allergic inflammatory disease of the upper airways.
|
Am J Respir Crit Care Med
|
2000
|
0.93
|
52
|
The immunological similarity of rat glandular kallikreins.
|
Biochem J
|
1977
|
0.93
|
53
|
Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air.
|
Am Rev Respir Dis
|
1986
|
0.92
|
54
|
Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis.
|
J Immunol
|
1987
|
0.92
|
55
|
Sinus mucosal IL-8 gene expression in chronic rhinosinusitis.
|
J Allergy Clin Immunol
|
1999
|
0.92
|
56
|
Kallikrein-kinin and renin-angiotensin systems in rat renal lymph.
|
Kidney Int
|
1984
|
0.92
|
57
|
Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis.
|
J Immunol
|
1986
|
0.91
|
58
|
Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo.
|
J Allergy Clin Immunol
|
2001
|
0.90
|
59
|
Radioimmunoassay of human high molecular weight kininogen in normal and deficient plasmas.
|
J Lab Clin Med
|
1980
|
0.90
|
60
|
Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction.
|
J Biol Chem
|
1998
|
0.89
|
61
|
Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects.
|
Am Rev Respir Dis
|
1990
|
0.89
|
62
|
Characterization and origin of immunoreactive glandular kallikrein in rat plasma.
|
Biochem Pharmacol
|
1981
|
0.89
|
63
|
Acute respiratory response to prolonged, moderate levels of sidestream tobacco smoke.
|
J Toxicol Environ Health A
|
1998
|
0.89
|
64
|
Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells.
|
Am J Respir Cell Mol Biol
|
2001
|
0.89
|
65
|
Platelet activation in the lung after antigen challenge in a model of allergic asthma.
|
Am Rev Respir Dis
|
1992
|
0.88
|
66
|
Preincubation of human synovial cells with IL-1 modulates prostaglandin E2 release in response to bradykinin.
|
J Immunol
|
1989
|
0.88
|
67
|
Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions.
|
J Immunol
|
1986
|
0.88
|
68
|
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.
|
Ann Allergy
|
1989
|
0.87
|
69
|
The location of prekallikrein in the rat pancreas [proceedings].
|
Biochem Soc Trans
|
1977
|
0.87
|
70
|
Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance.
|
Am J Respir Cell Mol Biol
|
2000
|
0.87
|
71
|
Distribution of immunoreactive kallikrein along the rat nephron.
|
Am J Physiol
|
1983
|
0.87
|
72
|
The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air.
|
Am Rev Respir Dis
|
1988
|
0.87
|
73
|
Observations on the pathogenesis of nasal priming.
|
J Allergy Clin Immunol
|
1989
|
0.86
|
74
|
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
|
Eur Respir J
|
2008
|
0.86
|
75
|
Nasal provocation with allergen induces a secondary serum IgE antibody response.
|
J Allergy Clin Immunol
|
1997
|
0.86
|
76
|
Differences between basophils and mast cells: failure to detect Charcot-Leyden crystal protein (lysophospholipase) and eosinophil granule major basic protein in human mast cells.
|
J Immunol
|
1986
|
0.85
|
77
|
Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells.
|
J Allergy Clin Immunol
|
1991
|
0.85
|
78
|
Profiling of bisenoic prostaglandins and thromboxane B2 in bronchoalveolar fluid from the lower respiratory tract of human subjects by combined capillary gas chromatography-mass spectrometry.
|
Prostaglandins
|
1988
|
0.84
|
79
|
Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx.
|
J Allergy Clin Immunol
|
1989
|
0.84
|
80
|
A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin.
|
Br J Clin Pharmacol
|
1991
|
0.84
|
81
|
Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes.
|
J Allergy Clin Immunol
|
1996
|
0.84
|
82
|
Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge.
|
Clin Exp Allergy
|
1998
|
0.84
|
83
|
Ozone exposure in humans: inflammatory, small and peripheral airway responses.
|
Am J Respir Crit Care Med
|
1995
|
0.84
|
84
|
Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides.
|
J Clin Invest
|
1992
|
0.84
|
85
|
Effects of intranasal administration of endothelin-1 to allergic and nonallergic individuals.
|
Am J Respir Crit Care Med
|
1995
|
0.84
|
86
|
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells.
|
J Allergy Clin Immunol
|
1984
|
0.83
|
87
|
Inflammatory mediators in nasal secretions during induced rhinitis.
|
Clin Allergy
|
1986
|
0.83
|
88
|
The human nasal response to capsaicin.
|
J Allergy Clin Immunol
|
1994
|
0.83
|
89
|
Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation.
|
JAMA
|
1986
|
0.82
|
90
|
Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis.
|
J Immunol
|
1986
|
0.82
|
91
|
Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose.
|
Am Rev Respir Dis
|
1990
|
0.82
|
92
|
Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis.
|
Am J Med
|
1985
|
0.81
|
93
|
Measles virus infection synergizes with IL-4 in IgE class switching.
|
J Immunol
|
1999
|
0.81
|
94
|
Antigen-provoked increase in histamine reactivity. Observations on mechanisms.
|
Am Rev Respir Dis
|
1991
|
0.81
|
95
|
Responses to ragweed-pollen nasal challenge before and after immunotherapy.
|
J Allergy Clin Immunol
|
1989
|
0.81
|
96
|
Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine.
|
J Allergy Clin Immunol
|
1992
|
0.81
|
97
|
Allergen-induced hyperresponsiveness to bradykinin is more pronounced than that to methacholine.
|
J Appl Physiol (1985)
|
1995
|
0.81
|
98
|
Arachidonic acid metabolites during nasal challenge.
|
Arch Otolaryngol Head Neck Surg
|
1987
|
0.81
|
99
|
Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy.
|
Clin Exp Allergy
|
1990
|
0.80
|
100
|
A double-blind study of the discontinuation of ragweed immunotherapy.
|
J Allergy Clin Immunol
|
1997
|
0.80
|
101
|
Relationship between histamine and physiological changes during the early response to nasal antigen provocation.
|
J Appl Physiol (1985)
|
1999
|
0.80
|
102
|
Interaction of platelet-activating factor with cultured guinea pig tracheal epithelial cells.
|
Biochem J
|
1991
|
0.80
|
103
|
The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine.
|
J Allergy Clin Immunol
|
1987
|
0.80
|
104
|
Comparison of the responses of B1 and B2 kinin receptors to agonist stimulation.
|
Immunopharmacology
|
1999
|
0.80
|
105
|
Mechanisms of prostanoid synthesis in human synovial cells: cytokine-peptide synergism.
|
Inflammation
|
1996
|
0.80
|
106
|
Clinical and immunologic effects of component peptides in Allervax Cat.
|
Int Arch Allergy Immunol
|
1997
|
0.80
|
107
|
Kinins are generated in nasal secretions during influenza A infections in ferrets.
|
Am Rev Respir Dis
|
1990
|
0.80
|
108
|
Effect of alterations in extracellular fluid volume on urinary kallikrein in the conscious rat.
|
Hypertension
|
1982
|
0.80
|
109
|
Effects of loratadine and terfenadine on the induced nasal allergic reaction.
|
Arch Otolaryngol Head Neck Surg
|
1996
|
0.80
|
110
|
Rapid purification of a prekallikrein from rat pancreas.
|
Anal Biochem
|
1981
|
0.80
|
111
|
The pathophysiology of human mast cells. In vitro and in vivo function.
|
Am Rev Respir Dis
|
1987
|
0.79
|
112
|
Theophylline reduces histamine release during pollen-induced rhinitis.
|
J Allergy Clin Immunol
|
1986
|
0.79
|
113
|
Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection.
|
Pediatr Infect Dis J
|
1988
|
0.79
|
114
|
A new kinin moiety in human plasma kininogens.
|
Biochem Biophys Res Commun
|
1988
|
0.79
|
115
|
Modulation of kinin responses in human synovium by interleukin-1.
|
Agents Actions Suppl
|
1992
|
0.78
|
116
|
Creatine supplementation as an exercise performance enhancer for patients with COPD? An idea to run with.
|
Thorax
|
2005
|
0.78
|
117
|
Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin.
|
Biochem Pharmacol
|
1991
|
0.78
|
118
|
The effect of cetirizine on early allergic response.
|
Laryngoscope
|
1989
|
0.78
|
119
|
Experimentally induced nasal allergic responses.
|
J Allergy Clin Immunol
|
1988
|
0.78
|
120
|
Bradykinin is a potent and relatively selective stimulus for cytosolic calcium elevation in human synovial cells.
|
J Immunol
|
1994
|
0.78
|
121
|
Transient exposure of human bronchial epithelial cells to cytokines leads to persistent increased expression of ICAM-1.
|
Inflammation
|
2001
|
0.78
|
122
|
Effects of restriction of sodium or administration of fludrocortisone on parotid salivary kallikrein in man.
|
J Lab Clin Med
|
1982
|
0.78
|
123
|
A sensitive colorimetric assay for the release of tryptase from human lung mast cells in vitro.
|
J Immunol Methods
|
1993
|
0.78
|
124
|
Theophylline reduces the response to nasal challenge with antigen.
|
Am J Med
|
1985
|
0.78
|
125
|
Plasma extravasation through neuronal stimulation in human nasal mucosa in the setting of allergic rhinitis.
|
J Appl Physiol (1985)
|
1998
|
0.77
|
126
|
The role of kinins in human allergic disease.
|
N Engl Reg Allergy Proc
|
1987
|
0.77
|
127
|
Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells.
|
J Allergy Clin Immunol
|
1990
|
0.77
|
128
|
Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways.
|
Am J Respir Crit Care Med
|
1996
|
0.77
|
129
|
Characterization of GTP-binding proteins coupled to inhibition of adenylyl cyclase in guinea pig tracheal epithelial cells.
|
Am J Respir Cell Mol Biol
|
1994
|
0.77
|
130
|
Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype.
|
Int Arch Allergy Appl Immunol
|
1991
|
0.77
|
131
|
The effect of azelastine on the early allergic response.
|
Clin Exp Allergy
|
1992
|
0.77
|
132
|
Local application of atropine attenuates the upper airway reaction to cold, dry air.
|
Am Rev Respir Dis
|
1992
|
0.77
|
133
|
Induction of histamine release from human skin mast cells by bradykinin analogs.
|
Biochem Pharmacol
|
1989
|
0.77
|
134
|
Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose.
|
J Appl Physiol (1985)
|
1995
|
0.77
|
135
|
Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions?
|
Am Rev Respir Dis
|
1987
|
0.76
|
136
|
Inhibition of human bronchial kallikrein in asthma.
|
Am Rev Respir Dis
|
1989
|
0.76
|
137
|
Enhancement of afferent nerve excitability in the airways by allergic inflammation.
|
Pulm Pharmacol
|
1996
|
0.76
|
138
|
Allergen-induced changes in airway responsiveness are not related to indices of airway edema.
|
J Allergy Clin Immunol
|
2001
|
0.76
|
139
|
Bradykinin analog induce histamine release from human skin mast cells.
|
Adv Exp Med Biol
|
1989
|
0.76
|
140
|
Soluble intracellular adhesion molecule 1 in bronchoalveolar lavage fluid of allergic subjects following segmental antigen challenge.
|
Am J Respir Crit Care Med
|
1994
|
0.76
|
141
|
Disassociation of the release of histamine and arachidonic acid metabolites from osmotically activated basophils and human lung mast cells.
|
Am Rev Respir Dis
|
1990
|
0.75
|
142
|
Airways hyper-responsiveness to bradykinin and methacholine: effects of inhaled fluticasone.
|
Clin Exp Allergy
|
2002
|
0.75
|
143
|
The effect of a leukotriene antagonist on the early response to antigen.
|
Otolaryngol Head Neck Surg
|
1990
|
0.75
|
144
|
Stronger nasal responsiveness to cold air in individuals with rhinitis and asthma, compared with rhinitis alone.
|
Clin Exp Allergy
|
2006
|
0.75
|
145
|
Human plasma prekallikrein and high molecular weight kininogen decrease during parturition.
|
Thromb Res
|
1984
|
0.75
|
146
|
Nasal challenge with cold, dry air induces a late-phase reaction.
|
Am Rev Respir Dis
|
1988
|
0.75
|
147
|
Burning up the disposable income.
|
Health Serv J
|
1988
|
0.75
|
148
|
Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen.
|
Clin Exp Allergy
|
1990
|
0.75
|
149
|
Histamine release from human basophils is induced by IgE-dependent factor(s) derived from human lung macrophages and an Fc epsilon receptor-positive human B cell line.
|
Trans Assoc Am Physicians
|
1985
|
0.75
|
150
|
The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction.
|
Allergy
|
1987
|
0.75
|
151
|
Kininogens in nasal secretions after allergen challenge.
|
Adv Exp Med Biol
|
1986
|
0.75
|
152
|
Cardiac transplantation.
|
Lamp
|
1989
|
0.75
|
153
|
Pharmacology of upper airways challenge.
|
Int Arch Allergy Appl Immunol
|
1987
|
0.75
|
154
|
Cardiac transplant. A nursing perspective.
|
Qld Nurse
|
1985
|
0.75
|
155
|
Observations on nasal late phase reactions.
|
Immunol Invest
|
1988
|
0.75
|
156
|
Sodium-retaining steroids increase parotid salivary kallikrein.
|
Adv Exp Med Biol
|
1983
|
0.75
|
157
|
Airway neural responses to kinins: tachyphylaxis and role of receptor subtypes.
|
Am J Respir Crit Care Med
|
1999
|
0.75
|
158
|
Kinins as mediators of human allergic reactions.
|
Adv Exp Med Biol
|
1986
|
0.75
|
159
|
The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
|
J Allergy Clin Immunol
|
1992
|
0.75
|
160
|
Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness.
|
Int Arch Allergy Appl Immunol
|
1991
|
0.75
|
161
|
The role of inflammatory mediators in allergic rhinitis.
|
Ear Nose Throat J
|
1986
|
0.75
|
162
|
Origin of late phase histamine release.
|
J Allergy Clin Immunol
|
1996
|
0.75
|
163
|
Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air.
|
Am Rev Respir Dis
|
1991
|
0.75
|
164
|
Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
|
J Allergy Clin Immunol
|
1989
|
0.75
|
165
|
Lack of effect of hot, humid air on response to nasal challenge with histamine.
|
Ann Otol Rhinol Laryngol
|
1996
|
0.75
|
166
|
Immunoreactive kallikrein in rat renal lymph.
|
Adv Exp Med Biol
|
1983
|
0.75
|
167
|
Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning.
|
Laryngoscope
|
1992
|
0.75
|
168
|
The effects of H1 antihistamines on the early allergic response.
|
Ann Allergy
|
1989
|
0.75
|
169
|
Daily variations of serum diamine oxidase and the influence of H1 and H2 blockers: a critical approach to routine diamine oxidase assessment.
|
Inflamm Res
|
1998
|
0.75
|
170
|
Treatment with hot, humid air reduces the nasal response to allergen challenge.
|
J Allergy Clin Immunol
|
1997
|
0.75
|
171
|
Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
|
Clin Exp Allergy
|
1990
|
0.75
|
172
|
Localized antigen challenge of the nasal mucosa.
|
Arch Otolaryngol Head Neck Surg
|
1990
|
0.75
|